← Compare landing
Porton Advanced vs SCTbio
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Porton Advanced | SCTbio |
|---|---|---|
| Summary | End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. | SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/porton-advanced/sctbio.md